NPI: 1831153980 · YAKIMA, WA 98902 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 33,886 | $830K |
| 2019 | 30,597 | $1.00M |
| 2020 | 36,602 | $1.04M |
| 2021 | 36,748 | $969K |
| 2022 | 33,927 | $945K |
| 2023 | 17,835 | $794K |
| 2024 | 4,874 | $522K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 70,868 | 4,859 | $4.64M |
| A4657 | Syringe, with or without needle, each | 10,095 | 3,894 | $1.08M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 63,983 | 3,341 | $226K |
| J1756 | Injection, iron sucrose, 1 mg | 11,898 | 3,248 | $71K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,065 | 509 | $59K |
| A4913 | Miscellaneous dialysis supplies, not otherwise specified | 2,200 | 1,458 | $16K |
| G0008 | Administration of influenza virus vaccine | 192 | 154 | $11K |
| J1270 | Injection, doxercalciferol, 1 mcg | 19,449 | 2,309 | $4K |
| 90674 | 148 | 122 | $539.76 | |
| 85041 | 2,886 | 2,079 | $0.00 | |
| 85048 | 2,879 | 2,074 | $0.00 | |
| 83540 | 1,276 | 943 | $0.00 | |
| 83970 | 2,042 | 1,404 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 66 | 25 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 792 | 63 | $0.00 |
| 90662 | 92 | 66 | $0.00 | |
| 0004A | 22 | 13 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,424 | 813 | $0.00 |
| 82728 | 1,169 | 868 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 861 | 638 | $0.00 |
| 83550 | 1,062 | 829 | $0.00 |